Ambitious and self-motivated professional with a specific interest in diagnostic imaging medical physics and radiation protection. Graduate of Union University with a BS in Physics, University of Alabama at Birmingham with an MS in Health Physics, and currently pursing a Professional Doctorate in Medical Physics at Vanderbilt University, graduating May 2029.
The Medical Health Physics track focuses on applying radiation principles in the health care setting to protect staff, members of the public, and patients from unnecessary radiation exposure. Students will work on projects to improve radiation safety practices in radiology, nuclear medicine, radiation oncology, or research. Areas of investigation may include:
Basic Life Support (CPR and AED) Program American Heart Association March 2021
Determination of Liquid Viscosity Using a Bluetooth PASCO Smart Cart Union University Department of Physics August 2020 - May 2021
A viscometer, or viscosimeter, is an instrument used to measure the viscosity of a fluid. The goal of this research project is to experimentally determine the resistance coefficients of viscous fluids and compare to accepted values measured by a viscometer.
A sphere of mass m is attached to a PASCO Bluetooth Smart Cart and submerged in a viscous fluid. The smart cart will act as our viscometer. The mass falls through the liquid when the cart is released from rest, and the velocity of the cart is applied with Stokes’ Law to determine a value for the viscosity of the fluid.
Radioactive Seed Localization for Nonpalpable Breast Lesions Mayo Clinic - Jacksonville, FL May 2024 - August 2024
I-125 radioactive seed localization represents a significant advancement in the localization of nonpalpable breast lesions. Its advantages over traditional wire-guided localization, including improved scheduling flexibility, reduced patient discomfort, and enhanced surgical precision, make it a promising alternative for breast cancer surgery. As more institutions adopt this technique and further research is conducted, I-125 RSL has the potential to become the new standard of care in the localization of nonpalpable breast lesions.